Recon: Roche to market $50 flu pill to US cash buyers; Praxis surges on positive results from shaking disorder trials
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.In Focus: US
- Roche to sell flu pill for $50 to cash-paying US patients (Reuters)
- Novo vs. KBP Chapter 3: Fraud or due diligence slipup? (Fierce Pharma)
- What J&J’s ortho spinoff means for the industry (MedTech Dive)
- Obesity remains high in the US, but more states are showing progress, a new report finds (The Hill)
- Successful Diagnostics Alter Clinical Pathways, Says NHS Foundation Trust Leader (MedTech Insight)
- AstraZeneca Gets Rare Sell as Deutsche Bank Has Pipeline Worries (Bloomberg)
- Dianthus inks licensing deal with Chinese biotech; C4 targets $125M offering (Endpoints)
- Germany's Merck eyes life science deals, but muted 2026 outlook knocks shares (Reuters)
- Nordic Capital-led consortium raises takeover price for Bavarian Nordic to $39 per share (Reuters)
- Fixing The Fractures: New Aspirations For EU Medtech Regulatory Progress (MedTech Insight)
- J&J faces first UK lawsuits alleging its baby powder caused cancer (Reuters)
- Veteran biotech executive Clive Meanwell on drug pricing and the obesity market (STAT)
- Funding cuts threaten new generation of cancer immunotherapies, researcher says (STAT)
- This scientist is revealing the immune system in our nasal passages (STAT)
- Baby KJ’s doctors will ask FDA this winter to OK a clinical trial of pioneering gene editing approach (STAT)
- Pharmanovia Seeks to Reassure Lenders as Performance Wanes (Bloomberg)
- Are PD-1xVEGF bispecifics being tested in the wrong kinds of cancer? (Endpoints)
- Novartis’ Fabhalta gets confirmatory late-stage trial win in kidney disease IgAN (Endpoints)
- Praxis surges as drug improves daily function for movement disorder patients in trials (Reuters)
- J&J eyes earlier myeloma treatment with ph. 3 Tecvayli combo win (Fierce Pharma)
- Diabetes drug soothes brain inflammation in female mice with MS (Fierce Pharma)
- Medical device maker Becton Dickinson's CFO to depart; shares slide (Reuters)
- Lyra launches ‘clinical-grade’ chatbot amid growing concern about mental health and AI (STAT)
- Thiel, Bezos Back Startup Treating Tumors With Sound Waves (Bloomberg)
- How wearable maker Whoop is making its move into healthcare (Endpoints)
- Town Hall Ventures raises $440M fund as it invests deeper into health tech (Endpoints)
- BD CFO Chris DelOrefice leaving for new job (MedTech Dive)
- Abbott CEO: ‘We’re right on time’ to the PFA party (MedTech Dive)
- In Texas, ex-vegan restaurateurs put MAHA’s vision for farming to the test (STAT)
- Food recalls are on the rise. What happens to the waste? (Food Dive)
- The Health-Care Debate That’s Driving the Shutdown (Again) (Bloomberg)
- ‘Doctor Mike,’ the popular YouTube creator, faults AMA communication strategies to counter misinformation (STAT)
- Democratic governors form a public health alliance in rebuke of Trump administration (STAT)
- Doctor groups need to ‘step up to the plate’ as CDC guidance becomes harder to trust, former leaders say (STAT)
- Medicare backs off plan to pause doctor payments amid shutdown (STAT)
- Idaho First to Pull Back the Curtain on Health Insurance Pain (Bloomberg)
- Court blocks Cosette's attempt to drop $438 million Mayne deal; shares jump (Reuters)
A story’s inclusion in Regulatory Recon does not imply endorsement by Regulatory Focus or RAPS.
